CD44 and head and neck squamous cell carcinoma: Unsurprisingly, CD44 is aberrantly upregulated among diverse tumors, including pancreatic cancer, breast cancer, prostate cancer, head and neck squamous cell carcinoma, and gastrointestinal cancer (6).